Results 191 to 200 of about 19,745 (243)

Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report. [PDF]

Front Immunol
Chu MQ, Zhang TJ, Feng Y, Shao X, Ji YH, Qian J, Zhou JD.   +6 more
europepmc   +1 more source

Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. [PDF]

Antibodies (Basel)
In H, Park M, Lee H, Han KH.
europepmc   +1 more source

A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins. [PDF]

Sci Rep
Lacy ER, Nanjunda R, Klakamp SL, Kwok D, Nemeth JF, Powers GD, Caicedo HH, Jacobs SA.   +7 more
europepmc   +1 more source

Bispecific antibodies in clinical practice: Understanding recent advances and current place in cancer treatment landscape. [PDF]

Clin Exp Med
Verma V, Sharma G.
europepmc   +1 more source

A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology. [PDF]

Neurotherapeutics
Sehlin D, Roshanbin S, Zachrisson O, Ingelsson M, Syvänen S.   +4 more
europepmc   +1 more source

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1. [PDF]

Cancer Immunol Immunother
Kato H, Tsukahara T, Murata K, Nishikata H, Mizue Y, Sasaya T, Kubo T, Kanaseki T, Hirohashi Y, Oyagi A, Maeda T, Miyazaki A, Torigoe T.   +12 more
europepmc   +1 more source

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer. [PDF]

Front Immunol
Zhu Y, Yang Y, Yue L, Wan L, Ma X, Yang Q, Tian X, Li Y, Wang K, Wei S, Zuo D, Feng M.   +11 more
europepmc   +1 more source

Rapid affinity-based purification of multi-specific antibodies using Kappa Select and Protein L. [PDF]

MAbs
Mix K, Sun T, Hall B, Newton J, Eng C, Guo Y, Reczek D.   +6 more
europepmc   +1 more source

IGLV3-21^R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia

Fischer C, Stücheli S, Chen S, Nimmerfroh J, Schultheiß C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, Läubli H, Peipp M, Binder M.   +17 more
europepmc   +1 more source

Six events that shaped antibody approvals in oncology. [PDF]

Front Immunol
Paul S, Zhou S.
europepmc   +1 more source